Your Experiences with Psychedelic Substances - Safety and Inclusivity
Caution: JavaScript execution is disabled in your browser or for this website. You may not be able to answer all questions in this survey. Please, verify your browser parameters.

Your Experiences with Psychedelic Substances - Safety and Inclusivity



This project is being undertaken through the University of Southern Queensland. The purpose of this study is to understand people's experiences of using psychedelic substances. Increasingly, psychedelics are being used in a therapeutic context to treat a range of mental health concerns. We are interested in your perspectives on what might make psychedelic therapy more safe and inclusive, based on your own experience using a psychedelic substance. Findings from this study will help to inform the ongoing development and refinement of psychedelic psychotherapy protocols.

We are recruiting anyone who is over 18 and has had at least one experience using a ‘classic’ psychedelic compound. That could include psilocybin (i.e., magic mushrooms), LSD (i.e., acid), DMT (either as Ayahuasca or inhaled DMT), or mescaline (i.e., cactus juice). 


Your participation will involve completion of an online questionnaire that will take approximately 30 minutes of your time.

Questions will broadly explore your experiences using a classic psychedelic compound and also your perspectives on what you think might make psychedelic assisted psychotherapy more safe and inclusive. Some questions include, 1) what helped you to process / understand the experiences that arose during your psychedelic trip, and 2) describe what aspects of your psychedelic experience you found helpful or therapeutic. Feel free to provide as much or as little detail as you like or skip questions completely if you do not feel comfortable responding. There are no correct answers to the questions we will ask. You will be able to flow back and forth between questions as required to add or edit responses. All data collected is anonymous.

Your participation in this project is entirely voluntary. If you do not wish to take part, you are not obliged to. If you decide to take part and later change your mind, you are free to withdraw from the project at any stage. You will be unable to withdraw data collected about yourself after you have participated in the questionnaire due to the anonymous nature of the data. Your decision whether you take part, do not take part, or take part and then withdraw, will in no way impact your current or future relationship with the University of Southern Queensland or The University of Queensland.

Expected benefits

It is expected that this project will not directly benefit you. However, it may benefit others in the future by helping shape the way psychedelic therapy is designed to be more safe and inclusive for everyone.


During this survey you will not be asked to disclose any illegal activity, however this may inadvertently arise during participation. We are undertaking a variety of steps to protect your privacy and to not incriminate you in the event of disclosure of illegal activity. Firstly, data collected is anonymous and non-identifiable. In the potential instance that open-ended text provides data that may reveal your identity, we will redact responses to protect your privacy. Secondly, your data will be stored securely and anonymously. As well, the survey tool used to collect your information will not collect your IP address. By consenting to this research, you acknowledge this risk, and the intentional steps we are taking to protect your identity.

Outside of this,  participating in the questionnaire will pose no risk  beyond normal day-to-day living. Sometimes thinking about the sorts of issues raised in the questionnaire can create some uncomfortable or distressing feelings. If you need to talk to someone about this immediately, please contact your support networks, or access a service such as Lifeline: 131114 or Qlife: 1800184527. Attached to this document is a list of support services from around the globe that may be useful in helping you find a suitable service.

Privacy and Confidentiality

All comments and responses are confidential unless required by law. The names of individual persons are not required in any of the responses. Data may be used for future research purposes, however due to the anonymous nature of data collection, all responses are non-identifiable. Participants may contact the Principal Investigator Grace Wang for a 1–2-page summary of the project results in December 2024.

Any data collected as a part of this project will be stored securely, as per University of Southern Queensland’s Research Data and Primary Materials Management Procedure. Data collected will be non-identifiable and accessible only by members of the research team above which includes external researchers from UQ.  

Consent to participate

Clicking on the ‘Submit’ button at the conclusion of the questionnaire is accepted as an indication of your consent to participate in this project.


Please refer to the Research team contact details at the bottom of the form to have any questions answered or to request further information about this project.

Concerns or complaints

If you have any concerns or complaints about the ethical conduct of the project, you may contact the University of Southern Queensland, Manager of Research Integrity and Ethics on +61 7 4631 1839 or email The Manager of Research Integrity and Ethics is not connected with the research project and can address your concern in an unbiased manner.

Research team contact details

Principal Investigator:
A/Professor Grace Wang
Telephone: +61 7 4631 1340

Supervisor / Co-investigator(s):
Professor Amy Mullens

Dr Renee Ireland

Dr Riccardo Miceli McMillan

Mr James Fowler

Dr Samantha Brown

A/Professor Annette Bromdal

Support resources

Below is a list of services from different places around the world that you might like to contact if you experience any distress during this study.


Name of Service

Contact number / website


Mental Health America


National Suicide Hotline



The Trevor Project




1800 184 527 /



13 11 14


Stichting Zelfmoordlijn 1813 (Dutch)



Stichting Centre de Prévention du Suicide (French)



Centro de Valorização da Vida

188 /


Canada Suicide Prevention Service



Crisis Text Line

Via texting ‘HOME’ or ‘PARLER’ to 686868


LGBTQ Youth Line



Lifeline China

400 821 1215



70 201 201


Suicide Ecoute

0033 145 39 4000


Telefonseelsorge Deutschland (National)

German speaking: 0800-111 0 222

English speaking: 03-44 01 06 07


Samaritans – ONLUS

800 86 00 22


Telefono Amico





Befrienders Kenya

+254 722 178 177



(55) 5259-8121

New Zealand


0800 688 5463


Olsztynski Telefon Zaufania 'Anonimowy Przyjaciel

89 19288


Suicide Helpline

(495) 625 3101

South Africa

The Triangle Project

(021) 712 6699

South Korea

Lifeline Korea



Teléfono de la Esperanza


Sri Lanka

Sri Lanka Sumithrayo – Bandarawela

011 057 2222662


Befrienders Khartoum

(249) 11-555-253


Självmordslinjen (Suicide prevention hotline)



Lifeline Taiwan


United Arab Emirates

National Committee for the Promotion of Mental Health


United Kingdom


0300 304 7000

United Kingdom


0300 330 0630

This list is only a small number of resources available to you. Please see some of the following links if you require support and your country is not currently listed and or you don’t feel comfortable contacting the organizations listed:


Welcome to our survey exploring your experience with psychedelics compounds!

In this survey, we are interested in understanding your experience with psychedelic compounds (e.g., magic mushrooms/psilocybin, Ayahuasca, LSD, DMT). Given the rise in the use of psychedelic substances as a part of therapy, we are particularly interested in hearing your perspectives on how to make psychedelic assisted psychotherapy more inclusive and safe for everyone.

Please answer every question honestly and remember that all responses are completely anonymous. 

Please press the 'next' button to provide your informed consent and complete the survey.

There are 21 questions in this survey.